Form 4: Quest Diagnostics Director Reports Phantom Stock Unit Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Timothy C. Wentworth, a Director at Quest Diagnostics Inc., reported the acquisition of 198 phantom stock units on April 1, 2026, as part of his director compensation.

Summary

  • Timothy C. Wentworth, a Director of Quest Diagnostics Inc., has reported the acquisition of 198 phantom stock units.
  • These units were acquired on April 1, 2026, with a transaction code 'A' indicating acquisition.
  • The phantom stock units are a result of elective deferrals of a director's cash compensation.
  • They are part of the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors.
  • These units will become payable in cash upon the reporting person's termination of service as a director.
  • The reporting person's beneficial ownership of common stock is 198 units, held directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine disclosure of director compensation and does not contain new financial performance data or strategic shifts.

Positives

  • Director compensation structure includes deferred compensation plans, indicating a commitment to long-term director engagement.
  • The acquisition of phantom stock units by a director suggests continued participation and commitment to the company.

Risks

  • The value of the phantom stock units is tied to the company's common stock performance, thus subject to market volatility.
  • Payment of these units is contingent upon the reporting person's termination of service, introducing a potential timing risk for cash realization.

Future Outlook

The phantom stock units are expected to be paid in cash upon the reporting person's termination of service as a director.

Industry Context

StockSavvy.ai notes that the use of phantom stock units and deferred compensation plans is a common practice among publicly traded companies, particularly in the healthcare and diagnostics sector, to attract and retain experienced directors by aligning their interests with long-term shareholder value.

Stakeholder Impact

  • Shareholders: The filing provides transparency into director compensation, which is a component of corporate governance and can indirectly affect shareholder value through director retention and alignment.
  • Directors: The phantom stock units represent a form of deferred compensation, impacting the financial remuneration of directors.

Next Steps

  • Payment of phantom stock units in cash upon Timothy C. Wentworth's termination of service as a director.

Key Dates

DateDescription
04/01/2026Transaction date for the acquisition of phantom stock units.
04/02/2026Date of the signature for the filing.

Keywords

Quest Diagnostics, DGX, Form 4, Director Compensation, Phantom Stock Units, Deferred Compensation, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.